Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4 + T-cell count

Antiviral Therapy

Volumn 16, Issue 7, 2011, Pages 1057-1062

  Grinsztejn, Beatriz ^a   Smeaton, Laura ^b   Barnett, Ronald ^c   Klingman, Karin ^d   Hakim, James ^e   Flanigan, Timothy ^f   Kumarasamy, N ^g   Campbell, Thomas ^h   Currier, Judith ⁱ  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f BROWN UNIVERSITY   (United States)

^g YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ARTICLE; ASIA; CD4 LYMPHOCYTE COUNT; CENTRAL AMERICA; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SOUTH AMERICA; VIRUS LOAD;

ADULT; AFRICA; ANTI-HIV AGENTS; ASIA; CARIBBEAN REGION; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; NORTH AMERICA; RNA, VIRAL; SEX CHARACTERISTICS; SOUTH AMERICA; VIRAL LOAD; VIREMIA;

EID: 80055089252     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1872     Document Type: Article

References (22)

1. Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS epidemic update: December 2009. Geneva: UNAIDS/WHO 2009.
2. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510-1514. (Pubitemid 28512927)
3. Gandhi M, Bacchetti P, Miotti P, et al. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 2002; 35:313-322. (Pubitemid 34800281)
4. Rezza G, Lepri AC, D'Arminio Monforte A, et al. Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. ICONA Study Group. J Acquir Immune Defic Syndr 2000; 25:56-62.
5. Moore AL, Kirk O, Johnson AM, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr 2003; 32:452-461. (Pubitemid 36363161)
6. Trichavaroj R, de Souza MS, Buapunth P, et al. HIV viral load in Thai men and women with subtype E infections. J Acquir Immune Defic Syndr 2001; 26:345-347. (Pubitemid 32435999)
7. Sterling TR, Vlahov D, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344:720-725. (Pubitemid 32204989)
8. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS 2005; 19:357-370. (Pubitemid 40446182)
9. Touloumi G, Pantazis N, Babiker AG, et al. CASCADE Collaboration differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS 2004; 18:1697-1705. (Pubitemid 39095787)
10. Napravnik S, Poole C, Thomas JC, et al. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 2002; 31:11-19.
11. Sterling TR, Lyles CM, Vlahov D, et al. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis 1999; 180:666-672. (Pubitemid 29411351)
12. Shanker G, Sorci-Thomas M, Adams MR. Estrogen modulates the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res 1994; 13:377-382.
13. Mellors JW, Griffith BP, Ortiz MA, et al. Tumor necrosis factoralpha/ cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991; 163:78-82.
14. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS 2000; 14:2101-2107.
15. Pitt J, Moye J, Matthews Y, et al. Sex differences in immunologic and virologic markers in children born to women infected by human immunodeficiency virus (HIV). 8th Conference on Retroviruses and Opportunistic Infections. 4-8 February 2001, Chicago, IL, USA. Abstract 513.
16. Rhodes K, Scott A, Markhan RL, et al. Immunological sex differences. Ann Rheum Dis 1969; 28:104-120.
17. Sterling TR, Pisell-Noland T, Perez JL, et al. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J Infect Dis 2005; 191:881-885. (Pubitemid 40349802)
18. Portales P, Clot J, Corbeau P. Sex differences in HIV-1 viral load due to sex difference in CCR5 expression. Ann Intern Med 2001; 134:81-82. (Pubitemid 32037350)
19. Overton ET, Nurutdinova D, Freeman J, et al. Factors associated with renal dysfunction within an urban HIVinfected cohort in the era of highly active antiretroviral therapy. HIV Med 2009; 10:343-350.
20. Lucas GM, Lau B, Atta MG, et al. Chronic kidney disease incidence and progression to end-stage renal disease in HIVinfected individuals: a tale of two races. J Infect Dis 2008; 197:1548-1557. (Pubitemid 351706485)
21. Déti EK, Thiébaut R, Bonnet F, et al. Prevalence and factors associated with renal impairment in HIV-infected patients. HIV Med 2010; 11:308-317.
22. Tordato F, Cozzi Lepri A, Cicconi P, et al. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med 2011; 12:4-13.